Literature DB >> 25249355

Prompt diagnosis and effective treatment of Trichosporon asahii catheter-related infection in non-immunocompromised neurosurgical patient.

Zana Rubic1, Anita Novak, Zvonimir Tomic, Ivana Goic-Barisic, Marina Radic, Marija Tonkic.   

Abstract

Trichosporon asahii is a rare but emerging fungal pathogen that causes severe and life-threatening infections with high mortality rate, mostly in immunocompromised patients. It could be easily misdiagnosed due to lack of awareness, especially when invasive or deep-seated infections occur in non-immunocompromised patients, and inadequately treated since the clinical failures and high minimum inhibitory concentrations to some antifungal agents have been described. We present a case of T. asahii catheter-related infection in 66-year-old comatose patient with polytrauma, who was not immunodeficient, but was receiving broad-spectrum antibiotics for a long period. Due to prompt diagnosis and treatment which included catheter replacement and voriconazole, the patient successfully recovered from this infection. The aims of this case report were to highlight the importance of recognizing this otherwise colonizing yeast as potentially dangerous pathogen in non-immunocompromised patients with a long-term antibiotic therapy, and to emphasize the importance of the right therapeutic choice due to its resistance to certain antifungal agents.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25249355     DOI: 10.1007/s11046-014-9814-9

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  20 in total

Review 1.  Update on the genus Trichosporon.

Authors:  Thomas C Chagas-Neto; Guilherme M Chaves; Arnaldo L Colombo
Journal:  Mycopathologia       Date:  2008-06-21       Impact factor: 2.574

2.  Successful treatment of Trichosporon asahii infection with voriconazole after bone marrow transplant.

Authors:  Vikas Dua; Satya P Yadav; Jaswinder Oberoi; Anupam Sachdeva
Journal:  J Pediatr Hematol Oncol       Date:  2013-04       Impact factor: 1.289

3.  Susceptibility patterns and molecular identification of Trichosporon species.

Authors:  Juan L Rodriguez-Tudela; Teresa M Diaz-Guerra; Emilia Mellado; Virginia Cano; Cecilia Tapia; Alexander Perkins; Alicia Gomez-Lopez; Laura Rodero; Manuel Cuenca-Estrella
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

4.  Trichosporon asahii, a non-Candida yeast that caused fatal septic shock in a patient without cancer or neutropenia.

Authors:  J R Ebright; M R Fairfax; J A Vazquez
Journal:  Clin Infect Dis       Date:  2001-07-26       Impact factor: 9.079

5.  Multidrug-resistant Trichosporon asahii infection of nongranulocytopenic patients in three intensive care units.

Authors:  D G Wolf; R Falk; M Hacham; B Theelen; T Boekhout; G Scorzetti; M Shapiro; C Block; I F Salkin; I Polacheck
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

Review 6.  Finding the "missing 50%" of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care.

Authors:  Cornelius J Clancy; M Hong Nguyen
Journal:  Clin Infect Dis       Date:  2013-01-11       Impact factor: 9.079

7.  Trichosporon asahii as a prospective pathogen in solid organ transplant recipients.

Authors:  I Netsvyetayeva; E Swoboda-Kopeć; L Paczek; P Fiedor; M Sikora; M Jaworska-Zaremba; S Blachnio; M Luczak
Journal:  Mycoses       Date:  2008-08-13       Impact factor: 4.377

8.  Breakthrough Trichosporon asahii fungemia in neutropenic patient with acute leukemia while receiving caspofungin.

Authors:  G Bayramoglu; M Sonmez; I Tosun; K Aydin; F Aydin
Journal:  Infection       Date:  2007-09-19       Impact factor: 3.553

9.  Trichosporon asahii causing nosocomial urinary tract infections in intensive care unit patients: genotypes, virulence factors and antifungal susceptibility testing.

Authors:  Wei Sun; Jianrong Su; Shuzhen Xu; Donghui Yan
Journal:  J Med Microbiol       Date:  2012-09-06       Impact factor: 2.472

10.  ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections.

Authors:  M C Arendrup; T Boekhout; M Akova; J F Meis; O A Cornely; O Lortholary
Journal:  Clin Microbiol Infect       Date:  2014-04       Impact factor: 8.067

View more
  1 in total

1.  Integrated transcriptomic analysis of Trichosporon Asahii uncovers the core genes and pathways of fluconazole resistance.

Authors:  Haitao Li; Congmin Wang; Yong Chen; Shaoqiang Zhang; Rongya Yang
Journal:  Sci Rep       Date:  2017-12-19       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.